Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B Virus (HBV) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05177926
What this trial is testing

Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

Who this might be right for
Hepatitis B, ChronicMother to Child Transmission
Nanfang Hospital, Southern Medical University 330
Testing effectiveness (Phase 2)Study completedNCT00033163
What this trial is testing

A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT02836249
What this trial is testing

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Positive Hepatitis B (China)

Who this might be right for
HBVChronic HBV Infection
Gilead Sciences 181
Post-approval studies (Phase 4)Study completedNCT01519921
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 150
Large-scale testing (Phase 3)Study completedNCT00697866
What this trial is testing

Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control

Who this might be right for
Hepatitis B
GlaxoSmithKline 951
Early research (Phase 1)Study completedNCT05561673
What this trial is testing

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Who this might be right for
Hepatitis B
GlaxoSmithKline 122
Early research (Phase 1)WithdrawnNCT05867056
What this trial is testing

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

Who this might be right for
Hepatitis B, Chronic
Immunocore Ltd
Post-approval studies (Phase 4)UnknownNCT02588937
What this trial is testing

Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Chong Kun Dang Pharmaceutical 76
Not applicableStudy completedNCT03931239
What this trial is testing

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Vabiotech 222
Testing effectiveness (Phase 2)Study completedNCT04000737
What this trial is testing

YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma
Yiviva Inc. 62
Very early researchNot Yet RecruitingNCT06745973
What this trial is testing

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Epigenic Therapeutics, Inc 20
Early research (Phase 1)Ended earlyNCT06159062
What this trial is testing

A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B Virus Infection
Yangshengtang Co., Ltd 1
Not applicableStudy completedNCT00476723
What this trial is testing

HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection

Who this might be right for
HIVHepatitis-B
The HIV Netherlands Australia Thailand Research Collaboration 36
Not applicableEnrolling By InvitationNCT05956379
What this trial is testing

Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.

Who this might be right for
Chronic Hepatitis BNon-alcoholic Fatty Liver Disease
National Taiwan University Hospital 100
Not applicableUnknownNCT05094869
What this trial is testing

Prevention of HCC Using Mobile Phone Applications

Who this might be right for
Liver CirrhosisHepatitis B
Beijing Friendship Hospital 8,000
Post-approval studies (Phase 4)Study completedNCT03274102
What this trial is testing

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Who this might be right for
Hand, Foot and Mouth Disease
Sinovac Biotech Co., Ltd 780
Large-scale testing (Phase 3)Study completedNCT00291941
What this trial is testing

Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

Who this might be right for
Hepatitis B
Henogen 300
Not applicableUnknownNCT03920605
What this trial is testing

Optimized Treatment of Peginterferon Alfa 2a/2b in Treatment Experienced Patients With HBV Related Liver Fibrosis

Who this might be right for
Hepatitis BLiver Fibrosis
Third Affiliated Hospital, Sun Yat-Sen University 100
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Testing effectiveness (Phase 2)Study completedNCT01334567
What this trial is testing

Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan

Who this might be right for
Hepatitis B
Gilead Sciences 30
Next Page